HCT also has world first natural hand sanitiser effective against the surrogate of covid-19
HOLISTA ANNOUNCES SUCCESSFUL U.K. LAB TESTS SHOWING NATSHIELD’S ACTIVE INGREDIENT EFFICACY AGAINST THE SURROGATE OF COVID-19
KUALA LUMPUR/PERTH, 20 April 2020–Holista CollTech (HCT, “Holista”) announced today thatPath-Away®,a plant-based active ingredient for itsalcohol-free hand sanitisercalled Natshield™sold in international markets, has been tested by a leading U.K. bio-safety laboratory to bemore than 99.99% effective against the feline corona virus, a surrogate the COVID-19 novel corona virus.Path-Away®‘s ingredients are Generally Regarded As Safe (GRAS) certified, approved by the Food and Drug Administration (“FDA”) and exempted by the Environmental Protection Agency (“EPA”) –all in the United States under FIFRA 25(b) in the Code of Federal Regulations.
It is listed in theU.S.Pharmacopeia (“USP”) and has undergone successful USP-51 testing. Path-Away® is also approved by the American Food and Safety Authority and Environmental Protection Authority of New Zealand. It is developed by Global Infections Control Consultants LLC (“GICC LLC”), headquartered in South Carolina, United States. Holistais the global distributor of Path-Away® under the trademark NatShield™ hand sanitisercontaining3% of Path-Away®.While Path-Away® had already been proven previously to be effectiveas a broad-spectrum sanitisercapable of killing a range of viruses, bacteria and fungi without the use of alcoholor toxic chemicals, both GICC LLC and Holista decided to subject it to testsagainstasurrogate of the COVID-19 novel coronavirusby a recognised bio-safety laboratory using protocols that are accepted internationally. Path-Away® works by attaching itself to the virus and weakening its walls. It inhibits its ability to take up amino acids –theirbasic building block. This forces the viruses to clump together, in the process killing themselves, almost instantly. The compoundis environmentally safe with very low toxicity and does not harm humans and pets. RESULTSThe latest U.K. test results confirm that Path-Away® in Natshield™ has an efficacy of at 4.17Log (99.99% efficacy) within a minute against the feline coronavirus (surrogate of Covid-19)when tested at a concentration of 3%.This means that 99.99% of the virus is killed within a minute of exposuretoNatshield™-a huge attribute toan all-naturalsanitiserthat is free of alcohol and chemicals. The novel coronavirushasbeengiven the official name of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by the International Committee for Taxonomy of Viruses, while the WorldHealth Organisation has named the disease caused by the virusas Coronavirus disease 2019 (COVID-19).For personal use onlyCOVID-19’s ability to survive on surfaces for up to nine days while remaining aerosolized, or airborne, is among the reasons attributed for its rapid global spread in recent weeks. In view of rising infections and fatalities due to the pandemic, GICC LLC and Holista expedited the tests to confirm the efficacy ofPath-Away®against COVID-19for Natshield™ .The Company is now in the process of registeringNatshieldÔin Australia with the TGAand willalso apply for the permit toclaimit is effective against COVID-19 as per theseTGA guidelines. The Company will notmarket the product as effective against COVID-19 unless it obtains this registration. “Path-Away®wassubjected to highinternational standards of testing against COVID-19and we areelated by the results. We hope these results will advance the global efforts to combat the spread ofthis coronavirus, future contagions and even the common fluby something very natural and environmentally friendly,” said Dr. ArthurV. MartinPresident of GICCLLC. “This is highly significantforNatShield™. The results have satisfied the European standard that applies to areas and situations where disinfection is medically indicated. Thisscientific validation means that NatShield™can be used to sanitise the hands without the need forrinsing, can be applied to the face and even inside the nose without irritation and is not harmful even if swallowed. It may also be sprayed safely to sanitise a person’s immediate surrounding space, without anynegative effects,” said Dr. Rajen Manicka, CEO of Holista.NEXT STEPSHolista andGICC LLC have issued instructions tocommence further tests on Path-Away® to assess its efficacy against COVID-19via the more rigorous direct inoculation method.This additional testing is being conductedat Biosafety Laboratory approved by the Centers for Disease Control (“CDC” ) of the United States. Results are expected to be released as soon as the testing procedure is completed based on the current work schedule.Thisannouncement has been approved for release by all members of the Holista
Be the first to comment